Analysis of factors affecting nonalcoholic fatty liver disease in Chinese steel workers and risk assessment studies

Lipids in Health and Disease - Tập 22 - Trang 1-16 - 2023
Rui Meng1, Hui Wang1, Zhikang Si1, Xuelin Wang1, Zekun Zhao1, Haipeng Lu1, Yizhan Zheng1, Jiaqi Chen1, Huan Wang1, Jiaqi Hu1, Ling Xue1, Xiaoming Li1, Jian Sun1, Jianhui Wu1
1School of Public Health, North China University of Science and Technology, Caofeidian New Town, Tangshan, China

Tóm tắt

The global incidence of nonalcoholic fatty liver disease (NAFLD) is rapidly escalating, positioning it as a principal public health challenge with significant implications for population well-being. Given its status as a cornerstone of China's economic structure, the steel industry employs a substantial workforce, consequently bringing associated health issues under increasing scrutiny. Establishing a risk assessment model for NAFLD within steelworkers aids in disease risk stratification among this demographic, thereby facilitating early intervention measures to protect the health of this significant populace. Use of cross-sectional studies. A total of 3328 steelworkers who underwent occupational health evaluations between January and September 2017 were included in this study. Hepatic steatosis was uniformly diagnosed via abdominal ultrasound. Influential factors were pinpointed using chi-square (χ2) tests and unconditional logistic regression analysis, with model inclusion variables identified by pertinent literature. Assessment models encompassing logistic regression, random forest, and XGBoost were constructed, and their effectiveness was juxtaposed in terms of accuracy, area under the curve (AUC), and F1 score. Subsequently, a scoring system for NAFLD risk was established, premised on the optimal model. The findings indicated that sex, overweight, obesity, hyperuricemia, dyslipidemia, occupational dust exposure, and ALT serve as risk factors for NAFLD in steelworkers, with corresponding odds ratios (OR, 95% confidence interval (CI)) of 0.672 (0.487–0.928), 4.971 (3.981–6.207), 16.887 (12.99–21.953), 2.124 (1.77–2.548), 2.315 (1.63–3.288), 1.254 (1.014–1.551), and 3.629 (2.705–4.869), respectively. The sensitivity of the three models was reported as 0.607, 0.680 and 0.564, respectively, while the precision was 0.708, 0.643, and 0.701, respectively. The AUC measurements were 0.839, 0.839, and 0.832, and the Brier scores were 0.150, 0.153, and 0.155, respectively. The F1 score results were 0.654, 0.661, and 0.625, with log loss measures at 0.460, 0.661, and 0.564, respectively. R2 values were reported as 0.789, 0.771, and 0.778, respectively. Performance was comparable across all three models, with no significant differences observed. The NAFLD risk score system exhibited exceptional risk detection capabilities with an established cutoff value of 86. The study identified sex, BMI, dyslipidemia, hyperuricemia, occupational dust exposure, and ALT as significant risk factors for NAFLD among steelworkers. The traditional logistic regression model proved equally effective as the random forest and XGBoost models in assessing NAFLD risk. The optimal cutoff value for risk assessment was determined to be 86. This study provides clinicians with a visually accessible risk stratification approach to gauge the propensity for NAFLD in steelworkers, thereby aiding early identification and intervention among those at risk.

Tài liệu tham khảo

National Workshop on Fatty L, Alcoholic Liver Disease CSoHCMA, Fatty Liver Expert Committee CMDA. Guidelines of prevention and treatment for nonalcoholic fatty liver disease: a 2018 update. Zhonghua Gan Zang Bing Za Zhi. 2018;26:195–203.

Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, Swain MG, Congly SE, Kaplan GG, Shaheen AA. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7:851–61.

Cotter TG, Rinella M. Nonalcoholic Fatty Liver Disease 2020: The State of the Disease. Gastroenterology. 2020;158:1851–64.

Harrison SA, Gawrieh S, Roberts K, Lisanti CJ, Schwope RB, Cebe KM, Paradis V, Bedossa P, Aldridge Whitehead JM, Labordette A, et al. Prospective evaluation of the prevalence of nonalcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort. J Hepatol. 2021;75:284–91.

Zhang X, Wu M, Liu Z, Yuan H, Wu X, Shi T, Chen X, Zhang T. Increasing prevalence of NAFLD/NASH among children, adolescents and young adults from 1990 to 2017: a population-based observational study. BMJ Open. 2021;11:e042843.

Gutierrez-Grobe Y, Ponciano-Rodriguez G, Ramos MH, Uribe M, Mendez-Sanchez N. Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women The role of estrogens. Ann Hepatol. 2010;9:402–9.

Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of nonalcoholic fatty liver disease (NAFLD). Metabolism. 2016;65:1038–48.

Ding Y, Li B, Yan S, Zhang W, Guan S, Xing L, Lu C. Survey on the current prevalence of key chronic diseases among iron and steel workers in Anshan Steel in 2020. Occup Health Damage. 2022;37:133–7.

Diehl AM, Day C. Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis. N Engl J Med. 2017;377:2063–72.

Zhang S, Wang Y, Wang Z, Wang H, Xue C, Li Q, Guan W, Yuan J. Rotating night shift work and nonalcoholic fatty liver disease among steelworkers in China: a cross-sectional survey. Occup Environ Med. 2020;77:333–9.

Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Society of Hepatology. Guidelines for diagnosis and treatment of alcoholic liver disease (revised in 2010). Chin J Hepatol. 2010;18:167–70.

Chinese Diabetes Society. Chinese Guidelines for the Prevention and Treatment of Type 2 diabetes (2017 Edition). Chin J Pract Intern Med. 2018;38:292-344.

Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75:1334–57.

Zhu J, Gao R, Zhao S, Lu G, Zhao D, Li J. Guidelines for the prevention and treatment of dyslipidemia in Chinese adults (revised in 2016). Chin Circ J. 2016;31:937–53.

Lou X, He Q. Validity and Reliability of the International Physical Activity Questionnaire in Chinese Hemodialysis Patients: A Multicenter Study in China. Med Sci Monit. 2019;25:9402–8.

Fung TT, Chiuve SE, McCullough ML, Rexrode KM, Logroscino G, Hu FB. Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch Intern Med. 2008;168:713–20.

Branch of Liver Physicians of Chinese Medical Doctor Association. Practice guide for diagnosis and treatment of hyperuricemia in kidney disease in China (2017 version). Nat Med J China. 2017;97:1927–36.

Ministry of Health of the People’s Republic of China. GBZ/T 192.1–2007-Determination of dust in the air of workplace Part 1: Total dust concentration. Beijing: Standards Press of China; 2007.

Ministry of Health of the People’s Republic of China. GBZT189.7–2007-Measurement of Physical Agents in Workplace Part 7: Heart Stress. Beijing: Standards Press of China; 2007.

Ministry of Health of the People’s Republic of China. GBZ/T229.4–2012-Classification of Occupational Hazards at Workplaces Part 4: Occupational Exposure to Noise. Beijing: Standards Press of China; 2012.

Riley RD, Ensor J, Snell KIE, Harrell FE Jr, Martin GP, Reitsma JB, Moons KGM, Collins G, van Smeden M. Calculating the sample size required for developing a clinical prediction model. BMJ. 2020;368:m441.

Zhou J, Zhou F, Wang W, Zhang XJ, Ji YX, Zhang P, She ZG, Zhu L, Cai J, Li H. Epidemiological Features of NAFLD From 1999 to 2018 in China. Hepatology. 2020;71:1851–64.

Anderson EL, Howe LD, Jones HE, Higgins JP, Lawlor DA, Fraser A. The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis. PLoS ONE. 2015;10:e0140908.

Villanueva-Ortega E, Garces-Hernandez MJ, Herrera-Rosas A, Lopez-Alvarenga JC, Laresgoiti-Servitje E, Escobedo G, Queipo G, Cuevas-Covarrubias S, Garibay-Nieto GN. Gender-specific differences in clinical and metabolic variables associated with NAFLD in a Mexican pediatric population. Ann Hepatol. 2019;18:693–700.

Della Torre S. Nonalcoholic Fatty Liver Disease as a Canonical Example of Metabolic Inflammatory-Based Liver Disease Showing a Sex-Specific Prevalence: Relevance of Estrogen Signaling. Front Endocrinol (Lausanne). 2020;11:572490.

Lee YH, Kim SH, Kim SN, Kwon HJ, Kim JD, Oh JY, Jung YS. Sex-specific metabolic interactions between liver and adipose tissue in MCD diet-induced nonalcoholic fatty liver disease. Oncotarget. 2016;7:46959–71.

Milic S, Lulic D, Stimac D. Nonalcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. World J Gastroenterol. 2014;20:9330–7.

Gutierrez-Cuevas J, Santos A, Armendariz-Borunda J: Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases. Int J Mol Sci. 2021;22:11629.

Ma L, Hao J, Hu X, Zhao Z, Zhou L, Xin Y. The relationship between fat content, obesity related gene polymorphism and susceptibility to nonalcoholic fatty liver disease. J Clin Hepatol. 2022;38:2723–6.

Tsuneto A, Hida A, Sera N, Imaizumi M, Ichimaru S, Nakashima E, Seto S, Maemura K, Akahoshi M. Fatty liver incidence and predictive variables. Hypertens Res. 2010;33:638–43.

Sun DQ, Wu SJ, Liu WY, Wang LR, Chen YR, Zhang DC, Braddock M, Shi KQ, Song D, Zheng MH. Association of low-density lipoprotein cholesterol within the normal range and NAFLD in the nonobese Chinese population: a cross-sectional and longitudinal study. BMJ Open. 2016;6:e013781.

Katsiki N, Mikhailidis DP, Mantzoros CS. Nonalcoholic fatty liver disease and dyslipidemia: An update. Metabolism. 2016;65:1109–23.

Xie D, Zhao H, Lu J, He F, Liu W, Yu W, Wang Q, Hisatome I, Yamamoto T, Koyama H, Cheng J. High uric acid induces liver fat accumulation via ROS/JNK/AP-1 signaling. Am J Physiol Endocrinol Metab. 2021;320:E1032–43.

Abbasi S, Haleem N, Jadoon S, Farooq A. Association Of Non-Alcoholic Fatty Liver Disease With Serum Uric Acid. J Ayub Med Coll Abbottabad. 2019;31:64–6.

De Nucci S, Castellana F, Zupo R, Lampignano L, Di Chito M, Rinaldi R, Giannuzzi V, Cozzolongo R, Piazzolla G, Giannelli G, et al. Associations between serum biomarkers and nonalcoholic liver disease: Results of a clinical study of Mediterranean patients with obesity. Front Nutr. 2022;9:1002669.

Cue S, Yuan J. Analysis of the association between cumulative dust exposure and hypertension in workers of a large steel mill based on a restricted cubic spline model. Chin J Publ Heal. 2020;36:1286–91.

Oikonomou D, Georgiopoulos G, Katsi V, Kourek C, Tsioufis C, Alexopoulou A, Koutli E, Tousoulis D. Nonalcoholic fatty liver disease and hypertension: coprevalent or correlated? Eur J Gastroenterol Hepatol. 2018;30:979–85.

Jirapatnakul A, Yip R, Branch AD, Lewis S, Crane M, Yankelevitz DF, Henschke CI. Dose-response relationship between World Trade Center dust exposure and hepatic steatosis. Am J Ind Med. 2021;64:837–44.

Liang J, Zhou H, Cen Z, Liao Y, Liu Y. Health survey and analysis of workers exposed to noise and dust in a candy manufacturing enterprise. Chin J Ind Hyg Occup Dis. 2021;39:511–5.

Shao C, Cheng Q, Zhang S, Xiang X, Xu Y. Serum level of free thyroxine is an independent risk factor for nonalcoholic fatty liver disease in euthyroid people. Ann Palliat Med. 2022;11:655–62.

Ciardullo S, Perseghin G. Prevalence of elevated liver stiffness in patients with type 1 and type 2 diabetes: A systematic review and meta-analysis. Diabetes Res Clin Pract. 2022;190:109981.

Targher G, Corey KE, Byrne CD, Roden M. The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. Nat Rev Gastroenterol Hepatol. 2021;18:599–612.

Matsangidou M, Liampas A, Pittara M, Pattichi CS, Zis P. Machine Learning in Pain Medicine: An Up-To-Date Systematic Review. Pain Ther. 2021;10:1067–84.

Akazawa M, Hashimoto K. Artificial intelligence in gynecologic cancers: Current status and future challenges - A systematic review. Artif Intell Med. 2021;120:102164.

Li X. Application of stochastic forest model in classification and regression analysis. Chinese Bull Entomol. 2013;50:1190–7.

Li Z, Liu Z. Feature selection algorithm based on XG Boost. J Commun. 2019;40:101–8.

de Hond AAH, Kant IMJ, Honkoop PJ, Smith AD, Steyerberg EW, Sont JK. Machine learning did not beat logistic regression in time series prediction for severe asthma exacerbations. Sci Rep. 2022;12:20363.

Zhang Y, Razbek J, Li D, Yang L, Bao L, Xia W, Mao H, Daken M, Zhang X, Cao M. Construction of Xinjiang metabolic syndrome risk prediction model based on interpretable models. BMC Public Health. 2022;22:251.

Xie D, Lai R, Fu X, Wang H, Nie S. Prediction of nosocomial infection in ICU patients by logistic regression model. Chin J Nosocomiol. 2011;21:2424–6.

Chang Y, Yang J, Leng P. Application of Logistic Regression Model to Evaluate the Value of Ultrasound Elastography in the Differential Diagnosis of Breast Nodules. J Med. 2017;46:109–12.

Thông tin
Thông tin xuất bản

Lipids in Health and Disease

Tập 22

1-16

Thông tin tác giả